Literature DB >> 1375465

Increased interleukin 1 receptor, type I, at messenger RNA and protein level in skin fibroblasts from patients with systemic sclerosis.

Y Kawaguchi1, M Harigai, M Hara, K Suzuki, M Kawakami, T Ishizuka, T Hidaka, A Kitani, M Kawagoe, H Nakamura.   

Abstract

Summary. To elucidate the mechanisms of the fibrosis in systemic sclerosis (SSc) through the action of a cytokine, interleukin 1 (IL-1), we studied the specific biologic and biochemical features of interleukin 1 receptor (IL-1R) as expressed on the surfaces of fibroblast cells in cultures from 3 SSc patients and 3 normal donors. 125I-IL-1 beta binding assays revealed a high density of IL-1R on the cell surfaces of SSc fibroblasts as compared to those of normal subjects. We also found an enhanced expression of IL-1R messenger RNA (mRNA) in SSc fibroblasts, using Northern blot or slot blot analysis. These findings indicate that the expression of IL-1R on SSc fibroblasts were spontaneously induced at the transcriptional level. It is suggested that SSc fibroblasts are more sensitive to IL-1, and that the signal transduction of IL-1 through IL-1R may be eventually involved in the fibrosis of SSc.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375465     DOI: 10.1016/s0006-291x(05)80053-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

2.  Interleukin-1 receptor mRNA expression in activated bovine leukocytes in vitro.

Authors:  P W Yu; L A Schuler; C J Czuprynski
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

3.  Association of interleukin 1 family with systemic sclerosis.

Authors:  Li Zhang; Jun-Wei Yan; Yu-Jie Wang; Ya-Nan Wan; Bing-Xiang Wang; Jin-Hui Tao; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

4.  IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis.

Authors:  Y Kawaguchi
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.

Authors:  K Takagi; Y Kawaguchi; M Hara; T Sugiura; M Harigai; N Kamatani
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

6.  Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.

Authors:  E Selvi; S A Tripodi; M Catenaccio; S Lorenzini; D Chindamo; S Manganelli; R Romagnoli; F Ietta; L Paulesu; C Miracco; M Cintorino; R Marcolongo
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

Review 7.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

8.  IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis.

Authors:  Min-Jung Park; Su-Jin Moon; Eun-Jung Lee; Kyung-Ah Jung; Eun-Kyung Kim; Da-Som Kim; Jung-Ho Lee; Seung-Ki Kwok; Jun-Ki Min; Sung-Hwan Park; Mi-La Cho
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.